Explore
Porta Sophia

Press Releases

December 3, 2025 | 3rd Party Submission

Enveric Biosciences Canada U.S. Patent Application 18/848,314 | Porta Sophia Files Third Party Submission

Patent application: carboxylic acid substituted tryptamines

View Press Release

December 2, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/851,294 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for treatment of anxiety and comorbid psychiatric conditions

View Press Release

December 1, 2025 | Press Release

Monster Color Carnival LLC Relinquishes All Patent Rights in Response to Porta Sophia’s Inter Partes Review Challenging Patent on Psychedelic Administration via Vaporizer

Inter Partes Review Challenging Patent on Psychedelic Administration via Vaporizer

View Press Release

November 24, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/850,394 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for treatment of Postpartum Depression (PPD)

View Press Release

November 24, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/851,329 | Porta Sophia Files Third Party Submission

Patent application: therapeutic use of 5-MeO-DMT for treatment of postnatal depression

View Press Release

November 21, 2025 | 3rd Party Submission

PharmAla Biotech Inc. U.S. Patent Application 19/040,188 | Porta Sophia Files Third Party Submission

Patent application: non-racemic formulations of R- and S-MDMA

View Press Release

November 20, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/851,356 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for treatment of Postpartum Depression (PPD)

View Press Release

November 20, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/851,356 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for the treatment of Postpartum Depression (PPD)

View Press Release

November 14, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/851,322 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for treatment of Postpartum Depression (PPD)

View Press Release
Learn about the status and impact of Porta Sophia's third party submissions and observations.

View Our Summary Chart